Noyan, H. Et Al. 2021. Association of the kynurenine pathway metabolites with clinical, cognitive features and IL-1β levels in patients with schizophrenia spectrum disorder and their siblings. SCHIZOPHRENIA RESEARCH , vol.229 , 27-37.

Noyan, H., Erdag, E., Tüzün, E., Yaylim, L., Küçükhüseyin, Ö., Hakan, M. T., ... Guloksuz, S.(2021). Association of the kynurenine pathway metabolites with clinical, cognitive features and IL-1β levels in patients with schizophrenia spectrum disorder and their siblings. SCHIZOPHRENIA RESEARCH , vol.229, 27-37.

Noyan, HANDAN Et Al. "Association of the kynurenine pathway metabolites with clinical, cognitive features and IL-1β levels in patients with schizophrenia spectrum disorder and their siblings," SCHIZOPHRENIA RESEARCH , vol.229, 27-37, 2021

Noyan, HANDAN Et Al. "Association of the kynurenine pathway metabolites with clinical, cognitive features and IL-1β levels in patients with schizophrenia spectrum disorder and their siblings." SCHIZOPHRENIA RESEARCH , vol.229, pp.27-37, 2021

Noyan, H. Et Al. (2021) . "Association of the kynurenine pathway metabolites with clinical, cognitive features and IL-1β levels in patients with schizophrenia spectrum disorder and their siblings." SCHIZOPHRENIA RESEARCH , vol.229, pp.27-37.

@article{article, author={HANDAN NOYAN Et Al. }, title={Association of the kynurenine pathway metabolites with clinical, cognitive features and IL-1β levels in patients with schizophrenia spectrum disorder and their siblings}, journal={SCHIZOPHRENIA RESEARCH}, year=2021, pages={27-37} }